DocuSign, Inc. - Common Stock (NQ:DOCU)

69.99 +0.98 (+1.42%)

Delayed Quote Updated: 11:22 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DocuSign, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

47 48 Next >

Why DocuSign Stock Dropped Today ↗

February 05, 2024

Acquisition talks have reportedly cooled.

Via The Motley Fool

DOCU Stock Falls as Private Equity Firms Stall Out on DocuSign ↗

February 05, 2024

DOCU stock is in the red after it was reported that the talks of two private equity firms to buy the company had stalled out.

Via InvestorPlace

Unpacking the Latest Options Trading Trends in DocuSign ↗

February 05, 2024

Via Benzinga

In the world of growth stocks, NASDAQ:DOCU shines as a value proposition. ↗

February 05, 2024

In the world of growth stocks, DOCUSIGN INC (NASDAQ:DOCU) shines as a value proposition.

Via Chartmill

Down 73% in 3 Years, Can DocuSign Stock Make a Comeback in 2024? ↗

February 01, 2024

This beaten-down stock has been rallying in recent months.

Via The Motley Fool

Peering Into DocuSign's Recent Short Interest ↗

January 30, 2024

Via Benzinga

Looking For Other Tech Names Outside Of NVDA? Here's More! ↗

January 26, 2024

The tech rally has been lovely to investors over the past few months. The tech-heavy index QQQ (NASDAQ: QQQ) closed at all-time highs last week.

Via Benzinga

Why NASDAQ:DOCU Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

January 24, 2024

Exploring the Growth Potential of DOCUSIGN INC (NASDAQ:DOCU) as It Nears a Breakout.

Via Chartmill

Is DocuSign Stock a Buy? ↗

January 15, 2024

DocuSign is at a pivotal point in its history.

Via The Motley Fool

10 Information Technology Stocks With Whale Alerts In Today's Session ↗

January 26, 2024

Via Benzinga

1 Fantastic Growth Stock Down 80% Investors Can Buy Hand Over Fist in 2024 ↗

January 24, 2024

Picking up a small stake in this e-signature specialist could benefit your portfolio in the long run.

Via The Motley Fool

Activist Investors Are Acting Up ↗

January 17, 2024

We've also got a look at two stocks worth watching: Despegar and On Holding.

Via The Motley Fool

NVIDIA To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

January 16, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

2 Top AI Stocks Ready for a Bull Run ↗

January 13, 2024

Some AI stocks are slated to continue their momentum into 2024.

Via The Motley Fool

Topics Artificial Intelligence

Navigating 8 Analyst Ratings For DocuSign ↗

January 12, 2024

Via Benzinga

DocuSign Stock Jumped Nearly 10% Thursday: What Happened? ↗

January 11, 2024

New reports suggest multiple private equity firms are competing to acquire DocuSign.

Via Benzinga

NASDAQ:DOCU is showing decent growth, but is still valued reasonably. ↗

December 18, 2023

DOCUSIGN INC (NASDAQ:DOCU) is not too expensive for the growth it is showing.

Via Chartmill

3 Leading Tech Stocks to Buy in 2024 and Beyond ↗

January 13, 2024

These stocks are great long-term additions to any diversified portfolio.

Via The Motley Fool

How Interest Rates Matter In Possible DocuSign, Software Buyouts ↗

January 12, 2024

DOCU stock rose for a second day amid reports DocuSign could be acquired by a private equity firm such as Bain Capital or Hellman & Friedman.

Via Investor's Business Daily

DOCU Stock Alert: Is DocuSign Getting Ready for a Buyout? ↗

January 12, 2024

With two investment firms competing to take DocuSign private, DOCU stock may be able to exit on a relatively high note.

Via InvestorPlace

10 Information Technology Stocks With Whale Alerts In Today's Session ↗

January 12, 2024

Via Benzinga

DocuSign Stock Sees Relative Strength Rating Jump To 89 ↗

January 12, 2024

DocuSign shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 89.

Via Investor's Business Daily

In the world of growth stocks, NASDAQ:DOCU shines as a value proposition. ↗

January 11, 2024

Don't overlook NASDAQ:DOCU—a stock with solid growth prospects and a reasonable valuation.

Via Chartmill

Better Tech Stock: Palo Alto Networks vs. DocuSign ↗

January 07, 2024

Will the cybersecurity giant continue to outperform the leader in e-signature services?

Via The Motley Fool

3 Stocks to Profit as ‘Remote Work’ Is Here to Stay ↗

December 24, 2023

Work-from home and remote work jobs are rising, lending undervalued work-from-home stocks the necessary latitude to surge.

Via InvestorPlace

1 Spectacular Growth Stock Down 80% to Buy Hand Over Fist for 2024 ↗

December 22, 2023

This growth stock helps individuals and businesses streamline an inconvenient process.

Via The Motley Fool

Zoom's Nasdaq Exit: What's Next for the Former Pandemic Darling Stock? ↗

December 18, 2023

Zoom Video Communications Inc (NASDAQ: ZM) will cease to be a component of the Nasdaq 100 index as its stock performance lags behind significant equity benchmarks in 2023, with only a 5.7% rise.

Via Benzinga

Why Is FuelCell Energy (FCEL) Stock Up 4% Today? ↗

December 18, 2023

FuelCell Energy stock is rising on Monday as investors in FCEL react to plans to build a new pilot plant with the help of Exxon Mobil.

Via InvestorPlace

Why Are Shipping Stocks ZIM, GNK, EGLE, SBLK Up Today? ↗

December 18, 2023

Shipping stocks are up on Monday after BP announced that it will no longer be using shipping routes that travel through the Red Sea.

Via InvestorPlace

DOCU Stock Alert: DocuSign Is Exploring a Deal to Sell Itself ↗

December 18, 2023

DOCU stock soared on Friday following a report that DocuSign was exploring the possibility of selling itself.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

47 48 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.